Gradual decline in outpatient antibiotic prescriptions in paediatrics: A data warehouse-based 11-year cohort study

Leslie Grammatico-Guillon1,2, S Reza Jafarzadeh3, Emeline Laurent2,4

  • 1Medical School and School of Public Health, Boston University, Boston, MA, USA.

Insights

Antibiotic prescriptions in children decreased by over 5% annually from 2007-2017. This decline was observed across common antibiotic classes and was more pronounced in children with comorbid conditions, highlighting effective antimicrobial stewardship.

Area of Science:

  • Pediatric primary care
  • Antimicrobial stewardship
  • Public health surveillance

Background:

  • Antibiotic (AB) resistance is a growing global concern.
  • Understanding trends in pediatric antibiotic prescribing is crucial for effective antimicrobial stewardship.
  • Primary care settings are significant contributors to overall antibiotic use.

Purpose of the Study:

  • To describe trends in antibiotic prescriptions in children in primary care over an 11-year period.
  • To analyze the evolution of pediatric outpatient antibiotic prescriptions using time-series analyses.
  • To assess the impact of comorbid conditions on antibiotic prescribing patterns in children.

Main Methods:

  • Retrospective cohort study utilizing a large data warehouse (Massachusetts Health Disparities Repository).
  • Analysis of outpatient antibiotic prescriptions from 2007 to 2017.
  • Time-series analyses, including annual percent change (APC), were used to assess prescription trends.

Main Results:

  • Approximately 25,000 children were included, with 31,248 antibiotic prescriptions recorded.
  • Younger children received more antibiotic prescriptions.
  • Overall antibiotic prescriptions decreased by an average of 5.34% annually (APC = -5.34%).
  • Penicillins (46%) and macrolides (28%) were the most frequently prescribed antibiotic classes.
  • Children with comorbid conditions received significantly more antibiotics (30.3 vs 21.0 AB/100 child-years).
  • Antibiotic prescribing declined more substantially in children with comorbid conditions.

Conclusions:

  • Outpatient antibiotic prescribing in pediatrics demonstrated a gradual and consistent decline over the study period.
  • Persistent prescription differences were noted across age groups, conditions, and indications.
  • Routine care data warehouses facilitate automated surveillance, offering cost-effective tools for antimicrobial stewardship programs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
161
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
121
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
159
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
172
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
182